19 February 2025 - NICE has published final evidence-based recommendations on the use of selpercatinib (Retsevmo) for the treatment of ...
19 February 2025 - NICE has published final evidence-based recommendations on durvalumab (Imfinzi) with etoposide and either carboplatin or cisplatin ...
12 February 2025 - NICE has published final evidence-based recommendations on the use of olaparib (Lynparza) for the treatment of ...
12 February 2025 - NICE has published final evidence-based recommendations on the use of selpercatinib (Retsevmo) for the treatment of ...
12 February 2025 - NICE has published final evidence-based recommendations on the use of selpercatinib (Retsevmo) for the treatment of ...
12 February 2025 - NICE has published final evidence-based recommendations on the use of ganaxolone (Ztalmy) for the treatment of ...
10 February 2025 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
5 February 2025 - NICE has published final evidence-based recommendations on the use of pembrolizumab (Keytruda) for the adjuvant treatment ...
5 February 2025 - Evidence-based recommendations on elacestrant (Korserdu) for treating oestrogen receptor-positive HER2-negative advanced breast cancer with an ESR1 mutation ...
31 January 2025 - Recommendations made by the PBAC in December 2024 relating to the listing of medicines on the PBS ...
16 January 2025 - The rare muscle wasting disorder affects approximately 2,500 males in the UK at any one time. ...
13 January 2025 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
23 January 2025 - NICE has published final evidence-based recommendations on the use of vadadustat (Vafseo) for the treatment of ...
21 January 2025 - We have also recommended osimertinib for routine use on the NHS today. ...
9 January 2024 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...